Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001393825-21-000025
Filing Date
2021-02-09
Accepted
2021-02-09 14:25:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 DARE 13GA dare_13ga.htm SC 13G/A 54129
  Complete submission text file 0001393825-21-000025.txt   55929
Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

EIN.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Subject) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88094 | Film No.: 21605664
SIC: 2834 Pharmaceutical Preparations